DMiNetz Blog

BioNTech, Curevac and Co.: Patent Suspensions Threaten Germany’s Booming Biotech Industry


DER SPIEGEL 19/2021










SPIEGEL International






Curevac Co-founder Ingmar Hoerr: A significant Made-in-Germany component.



Curevac Co-founder Ingmar Hoerr: A significant Made-in-Germany component.


Foto: Sebastian Gollnow / dpa





Workers at the BioNTech factory in Marburg



Workers at the BioNTech factory in Marburg


Foto: Thomas Lohnes / AFP

More on the Vaccination Campaign

“Our situation would look quite a bit different if we had had a strong partner on board by last summer.”

CureVac CEO Franz-Werner Haas



Source link

chalkboard, story, blogging

Leave a Reply

Sign up for our Newsletter